3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
NETWORK
1
Study Type
Observational
2
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Carcinoma, Non-Small-Cell Lung
14
Prostatic Neoplasms
9
Leukemia, Myeloid, Acute
9
Endometrial Neoplasms
8
Breast Neoplasms
7
Oropharyngeal Neoplasms
5
Neoplasm Metastasis
5
Lung Neoplasms
5
Colonic Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Neoplasms
4
Multiple Myeloma
4
Melanoma
4
Lymphoma, Mantle-Cell
4
Lymphoma, Large B-Cell, Diffuse
4
Leukemia, Myelomonocytic, Acute
4
Leukemia, Monocytic, Acute
4
Leukemia, Megakaryoblastic, Acute
4
Leukemia, Lymphocytic, Chronic, B-Cell
4
Leukemia, Erythroblastic, Acute
4
Congenital Abnormalities
4
Colorectal Neoplasms
4
Stomach Neoplasms
3
Rectal Neoplasms
3
Neuroblastoma
3
Mouth Neoplasms
3
Lymphoma, Follicular
3
Leukemia
3
Esophageal Neoplasms
3
Brain Neoplasms
3
Interventions
human papillomavirus vaccine, L1 type 16, 18
36
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
29
Papillomavirus Vaccines
22
Vaccines
11
Human Papillomavirus Recombinant Vaccine nonavalent
11
Radiotherapy, Intensity-Modulated
7
Human Papillomavirus DNA Tests
7
Colposcopy
7
Cisplatin
7
Educational Status
6
Carboplatin
6
Blood Specimen Collection
6
Vaccines, Synthetic
5
Specimen Handling
5
Early Intervention, Educational
5
Vaginal Smears
4
Methods
4
Engerix-B
4
fludarabine
3
epigallocatechin gallate
3
artesunic acid
3
artemisinin
3
Watchful Waiting
3
Surveys and Questionnaires
3
Patient Navigation
3
Paclitaxel
3
Imiquimod
3
Hepatitis A Vaccines
3
Cyclophosphamide
3
halofantrine
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Papillomavirus Infections
×
Observation
×
Clear all
NCT02135419
2024-07-26
ANCHOR
AIDS Malignancy Consortium
Phase 3
Completed
4,446 enrolled
13 charts